Does WARFARIN Cause Benign prostatic hyperplasia? 23 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 23 reports of Benign prostatic hyperplasia have been filed in association with WARFARIN (Warfarin Sodium). This represents 0.1% of all adverse event reports for WARFARIN.
23
Reports of Benign prostatic hyperplasia with WARFARIN
0.1%
of all WARFARIN reports
14
Deaths
19
Hospitalizations
How Dangerous Is Benign prostatic hyperplasia From WARFARIN?
Of the 23 reports, 14 (60.9%) resulted in death, 19 (82.6%) required hospitalization, and 14 (60.9%) were considered life-threatening.
Is Benign prostatic hyperplasia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for WARFARIN. However, 23 reports have been filed with the FAERS database.
What Other Side Effects Does WARFARIN Cause?
International normalised ratio increased (5,622)
Haemorrhage (2,930)
Gastrointestinal haemorrhage (2,469)
Anaemia (2,409)
Drug interaction (2,056)
Fall (1,702)
Drug ineffective (1,658)
Epistaxis (1,498)
Contusion (1,467)
Dyspnoea (1,374)
What Other Drugs Cause Benign prostatic hyperplasia?
TADALAFIL (596)
TAMSULOSIN (304)
FINASTERIDE (266)
PANTOPRAZOLE (261)
PREDNISONE (257)
ALBUTEROL (254)
ASPIRIN (243)
TIOTROPIUM (235)
RAMIPRIL (193)
AMLODIPINE (179)